For newbies’ (or anyone’s) context, the NOPAIN Act starts in 2025 with the push in process to move it to 2024. Possible CMS insurance reimbursement to boot. Very exciting! Potential massive money-maker.
In light of the above, it’s worth a measured investment in BIEL since it’s not without risk, and there’s no guarantee a suitor will partner/buyout/merger, which is essential, imo, given the above.
Will it be BIEL? We have the FDA clearances, potentially disruptive portable PEMF product(s), no side effects. What’s not to like?
If so, unimaginable PPS ascent.
If not, all bets off.
Why off?
Simply because nothing else has worked in the past towards a sustained and appreciating PPS, no matter the reasons offered for it, valid or not.
All imo…as always noted.